Global RNA Therapeutics Market Analysis Report 2022: Future Growth Potential Driven by Co-Development Programs and Robust Clinical Trials for Diverse Disease Areas
20 juin 2022 08h03 HE
|
Research and Markets
Dublin, June 20, 2022 (GLOBE NEWSWIRE) -- The "Global RNA Therapeutics Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This research service provides an overview...
Viral Vectors and Plasmid DNA Global Market (2021 to 2026) - Featuring FUJIFILM Diosynth Biotechnologies, Thermo Fisher Scientific, Renova Therapeutics and Genzyme Corporation
24 mars 2022 06h03 HE
|
Research and Markets
Dublin, March 24, 2022 (GLOBE NEWSWIRE) -- The "Viral Vectors And Plasmid DNA Global Market Report 2022: By Product, By Application, By Disease, By End-User" report has been added to...
AGC Biologics Supports Omicron-based Vaccine Candidate Manufacturing with Starting Material
08 févr. 2022 19h00 HE
|
AGC Biologics
Heidelberg, Germany, Feb. 08, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced an expanded...
Global Viral and Non-Viral Vector Manufacturing Market 2022: Favorable Funding Scenario for Vector-Based Therapies | Rapid Uptake of Viral Vector to Develop Innovative Therapies
08 févr. 2022 04h18 HE
|
Research and Markets
Dublin, Feb. 08, 2022 (GLOBE NEWSWIRE) -- The "Global Viral and Non-Viral Vector Manufacturing Market: Focus on Vector Type, Application, Disease and Region - Analysis and Forecast, 2021-2031"...
Global Viral Vectors and Plasmid DNA 2021-2030 - Surge in Demand due to Increasing Number of COVID-19 Cases
19 janv. 2022 04h48 HE
|
Research and Markets
Dublin, Jan. 19, 2022 (GLOBE NEWSWIRE) -- The "Viral Vectors and Plasmid DNA Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's...
Global Viral Vectors and Plasmid DNA Manufacturing Market Forecasts 2021-2028: A USD 1,866.90 Million Market by 2028
01 oct. 2021 05h48 HE
|
Research and Markets
Dublin, Oct. 01, 2021 (GLOBE NEWSWIRE) -- The "Viral Vectors And Plasmid DNA Manufacturing Market Size By Product Type, By Application, By End Product, By Geographic Scope And Forecast" report has...
Vectorized Antibodies for In Vivo Expression Industry - Featuring Adverum Biotechnologies, Homology Medicines and BioNTech Among Others
13 juil. 2021 04h53 HE
|
Research and Markets
Dublin, July 13, 2021 (GLOBE NEWSWIRE) -- The "Vectorized Antibodies for In Vivo Expression by DNA and mRNA: A Landscape Analysis Of Stakeholders, Technologies, Targets, Business and Financing from...
World Cell and Gene Therapy Manufacturing Market Report 2021-2025
18 juin 2021 07h13 HE
|
Research and Markets
Dublin, June 18, 2021 (GLOBE NEWSWIRE) -- The "The Market for Cell and Gene Therapy Manufacturing - The Rise of CMOs & CDMOs (2021)" report has been added to ResearchAndMarkets.com's offering. ...
$8.6 Billion Viral Vectors and Plasmid DNA Manufacturing Markets, 2028
17 juin 2021 06h08 HE
|
Research and Markets
Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Viral Vectors and Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report by Vector Type (AAV, Lentivirus), by Workflow, by...
Global Plasmid DNA Manufacturing Market to Surpass US$ 2,733.8 Million by 2028, Says Coherent Market Insights (CMI)
14 juin 2021 08h30 HE
|
CMI
SEATTLE, June 14, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the Global Plasmid DNA Manufacturing Market is estimated to be valued at US$ 635.1 million in 2021 and is expected...